[ ![]() |
Lee, Su-Jin
(Departments of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Choi, Joon-Young (Departments of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Kim, Ki-Hyun (Departments of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Lee, Eun-Jeong (Departments of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Cho, Young-Seok (Departments of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Hyun, Seung-Hyup (Departments of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Lee, Ji-Young (Departments of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Lee, Kyung-Han (Departments of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Kim, Byung-Tae (Departments of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) |
1 | Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975;36:842-54 DOI ScienceOn |
2 | Angtuaco EJ, Fassas AB, Walker R, Sethi R, Barlogie B. Multiple myeloma: clinical review and diagnostic imaging. Radiology 2004;231:11-23 DOI ScienceOn |
3 | Schirrmeister H, Bommer M, Buck AK, Muller S, Messer P, Bunjes D, Dohner H, Bergmann L, Reske SN. Initial results in the assessment of multiple myeloma using 18F-FDG PET. Eur J Nucl Med Mol Imaging 2002;29:361-6 DOI ScienceOn |
4 | Zamagni E, Nanni C, Patriarca F, Englaro E, Castellucci P, Geatti O, et al. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Haematologica 2007;92:50-5 DOI |
5 | Moulopoulos LA, Dimopoulos MA, Alexanian R, et al. Multiple myeloma: MR patterns of response to treatment. Radiology 1994;193:441-6 DOI |
6 | Bataille R, Durie BG, Grenier J, Sany J. Prognostic factors and staging in multiple myeloma: a reappraisal. J Clin Oncol 1986;4:80-7 DOI |
7 | Durie BG, Waxman AD, D'Agnolo A, Williams CM. Whole-body (18)F-FDG PET identifies high-risk myeloma. J Nucl Med 2002;43:1457-63 |
8 | Gertz MA. Relevant prognostic features of multiple myeloma and the new International Staging System. Leuk Lymphoma 2007;48:458-68 DOI ScienceOn |
9 | Jadvar H, Conti PS. Diagnostic utility of FDG PET in multiple myeloma. Skeletal Radiol 2002;31:690-4 DOI |
10 | Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, et al. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in Evaluation of Patients with Multiple Myeloma. J Nucl Med 2008;49:195-200 DOI ScienceOn |
11 | Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 2003;44:1200-9 |
12 | Van de Berg BC, Lecouvet FE, Michaux L, Labaisse M, Malghem J, Jamart J, et al. Stage I multiple myeloma: value of MR imaging of the bone marrow in the determination of prognosis. Radiology 1996;201:243-6 DOI |
13 | Bredella MA, Steinbach L, Caputo G, Segall G, Hawkins R. Value of FDG PET in the assessment of patients with multiple myeloma. AJR Am J Roentgenol 2005;184:1199-204 DOI ScienceOn |
14 | Durie BG. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system. Eur J Cancer 2006;42:1539-43 DOI ScienceOn |
![]() |